European technology companies operate in a capital market that has become both deeper and more fragmented. Growth equity, later-stage venture, private credit, structured instruments, infrastructure capital and strategic investment all now compete for the same businesses, on very different terms.
That breadth is an advantage for well-prepared companies and a source of confusion for others. The instruments are not interchangeable, and a structure that solves an immediate requirement can constrain the company's options at the next stage.
The relevant question is no longer whether capital exists, but which capital is appropriate.
Geography adds a further dimension. European businesses regularly attract capital from outside Europe, and international investors bring scale and comparative perspective alongside different expectations on governance, reporting and pace.
The practical consequence is that capital strategy has become a genuine strategic exercise rather than an administrative one. Choosing the instrument, the provider and the sequence deserves the same rigour as any other decision of comparable consequence.
For management teams, the useful discipline is to define the objective first and let the instrument follow. Capital raised without a clear view of what it is meant to prove tends to be expensive in ways that do not appear in the term sheet.
This commentary is provided for general information and reflects the views of Wrotham Partners at the time of writing. It does not constitute investment, legal or financial advice.